Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Markets

Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CASI
stocks logo

CASI Valuation

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)

CASI Relative Valuation

CASI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CASI is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
Median5y
0.00
FCF Yield
Median3y
Median5y

People Also Watch

FAQ

arrow icon

Is CASI Pharmaceuticals Inc (CASI) currently overvalued or undervalued?

CASI Pharmaceuticals Inc(CASI) is now in theFairzone, suggesting that its currentforward PEratio ofNaNis consideredFairlycompared with the five-year average of.The fair price of CASI Pharmaceuticals Inc(CASI)is betweentoaccording to relative valuation methord.
arrow icon

What is CASI Pharmaceuticals Inc (CASI) fair value?

CASI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price ofCASI Pharmaceuticals Inc (CASI) is between to according to relative valuation methord.
arrow icon

How does CASI's valuation metrics compare to the industry average?

The average P/S ratio for CASI's competitors is 26.47, providing a benchmark for relative valuation. CASI Pharmaceuticals Inc Corp (CASI) exhibits a P/S ratio of 0.85, which is -96.78% above the industry average. Given its robust revenue growth of 94.30%, this premium appearssustainable.
arrow icon

What is the current P/B ratio for CASI Pharmaceuticals Inc (CASI) as of Apr 04 2025?

As of Apr 04 2025, CASI Pharmaceuticals Inc (CASI) has a P/B ratio of . This indicates that the market values CASI at times its book value.
arrow icon

What is the current FCF Yield for CASI Pharmaceuticals Inc (CASI) as of Apr 04 2025?

As of Apr 04 2025, CASI Pharmaceuticals Inc (CASI) has a FCF Yield of%. This means that for every dollar of CASI Pharmaceuticals Inc’s market capitalization, the company generates cents in free cash flow.
arrow icon

What is the current Forward P/E ratio for CASI Pharmaceuticals Inc (CASI) as of Apr 04 2025?

As of Apr 04 2025, CASI Pharmaceuticals Inc (CASI) has a Forward P/E ratio of . This means the market is willing to pay $ for every dollar of CASI Pharmaceuticals Inc’s expected earnings over the next 12 months.
arrow icon

What is the current Forward P/S ratio for CASI Pharmaceuticals Inc (CASI) as of Apr 04 2025?

As of Apr 04 2025, CASI Pharmaceuticals Inc (CASI) has a Forward P/S ratio of . This means the market is valuing CASI at $ for every dollar of expected revenue over the next 12 months.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free